PDtrials Parkinson’s Clinical Research December 2008 Newsletter is now available. This edition features two new clinical trials (both beginning in the USA). The first study, sponsored by the National Institute of Neurological Disorders and Stroke (NINDS) will evaluate the therapeutic potential of transcranial magnetic stimulation (TMS) on symptoms of Parkinson’s Disease. People with mild to moderately severe PD who are between 40 and 80 years of age and whose main problems are slow movement and stiffness may be eligible for this study. The second study, sponsored by Department of Veterans Affairs, Rehabilitation Research and Development; University of Iowa, will examine the effects of aerobic exercise in motor and cognitive function in patients with Parkinson’s disease.
Also covered in this issue are:
* New Clinical Trials
* PDtrials Announces an Educational Webinar
* Older Antidepressants Work for Parkinson's Patients
* Pesticide Exposure Boosts Parkinson's Risk by 60 Percent
* Ceregene Therapy for Parkinson's Fails Phase II Trial
* New Longevity Drugs Poised to Tackle Diseases of Aging
* Schering-Plough's Phase II Parkinson's Trial Meets Primary Endpoint
* New Research Helps Explain Genetics of PD
Subscription to the free electronic newsletter is available here.
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment